Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Synta resumes clinical development of elesclomol

March 3, 2010

Bayer Schering claims new polo-like kinase 1 inhibitors

March 3, 2010

Rigel identifies AXL kinase inhibitors for cancer therapy

March 3, 2010

FDA requests Vion conduct phase II trial of Onrigin in AML prior to phase III study

March 2, 2010

Ariad's AP-24534 receives orphan drug status for CML

March 2, 2010

COMP grants perifosine positive opinion as orphan medicinal product in MM

March 2, 2010

UCB presents novel PI3K inhibitors

March 2, 2010

Genentech identifies novel MEK inhibitors

March 2, 2010

AstraZeneca discloses novel FGFR inhibitors

March 2, 2010

Virginia G. Piper Cancer Center and TGen begin phase I trial of Pharmacyclics' PCI-32765 in cancer

March 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...